Conserved Genes Act Modifiers Invertebrate SMN
Loss Function Defects
Maria Dimitriadi1., James N. Sleigh2,3., Amy Walker2., Howard C. Chang4, Anindya Sen4, Geetika
Kalloo1, Jevede Harris2, Tom Barsby2,3, Melissa B. Walsh5, John S. Satterlee2, Chris Li6, David Van
Vactor4, Spyros Artavanis-Tsakonas4,7, Anne C. Hart1*
1 Department Neuroscience, Brown University, Providence, Rhode Island, United States America, 2 Center Cancer Research, Massachusetts General Hospital,
Department Pathology, Harvard Medical School, Boston, Massachusetts, United States America, 3 Department Biology Biochemistry, University Bath, Bath,
United Kingdom, 4 Department Cell Biology, Harvard Medical School, Boston, Massachusetts, United States America, 5 Department Molecular Cellular Biology,
Brown University, Providence, Rhode Island, United States America, 6 Department Biology, City College – City University New York, New York, New York, United
States America, 7 Colle´ge France, Paris, France



     Abstract
     Spinal Muscular Atrophy (SMA) caused diminished function Survival Motor Neuron (SMN) protein,      molecular pathways critical SMA pathology remain elusive. used genetic approaches invertebrate models      identify conserved SMN loss function modifier genes. Drosophila melanogaster Caenorhabditis elegans      single gene encoding protein orthologous human SMN; diminished function invertebrate genes causes
     lethality neuromuscular defects. genes modulate SMN function defects species, approaches
     used.  genome-wide RNAi screen C. elegans SMN modifier genes undertaken, yielding genes.
     Second, tested conservation modifier gene function species; genes identified invertebrate model
     tested function invertebrate model. Drosophila orthologs genes, identified
     originally C. elegans, modified Drosophila SMN loss function defects. C. elegans orthologs genes,      originally identified previous Drosophila screen, modified C. elegans SMN loss function defects. Bioinformatic analysis
     conserved, cross-species, modifier genes suggests conserved cellular pathways, specifically endocytosis      mRNA regulation, act critical genetic modifiers SMN loss function defects species.

  Citation: Dimitriadi M, Sleigh JN, Walker  Chang HC, Sen  et al. (2010) Conserved Genes Act Modifiers Invertebrate SMN Loss Function Defects. PLoS
  Genet 6(10): e1001172. doi:10.1371/journal.pgen.1001172
  Editor: Gregory S. Barsh, Stanford University, United States America
  Received February 4, 2010; Accepted September 21, 2010; Published October 28, 2010
  open-access article distributed terms Creative Commons Public Domain declaration stipulates  placed public
  domain, work freely reproduced, distributed, transmitted, modified, built  used lawful purpose.
  Funding: work supported Spinal Muscular Atrophy Foundation (DVV, SA-T, ACH), National Institutes Health (NIH R01 NS42459) NIH/
  NCRR/RCMI Grant G12-RR03060 (CL), City College New York, respectively. NIH R01 NS26084 (SA-T) Families SMA Postdoctoral
  Fellowship  . nematode strains used work provided Caenorhabditis Genetics Center, funded NIH National Center   Research Resources. funders role study design, data collection analysis, decision publish, preparation manuscript.
  Competing Interests: authors declared competing interests exist.
  * E-mail: anne_hart@brown.edu
  . authors contributed equally work.




Introduction                                                                          proteins [11–19]. Roles SMN small nucleolar RNA
                                                                                      (snoRNA) microRNA (miRNA) pathways    Decreased Survival Motor Neuron (SMN) protein function                          suggested [20–22]. relative contributions SMN underlies Spinal Muscular Atrophy (SMA) cases [1].                           various compartments relative importance SMN
SMN protein ubiquitously expressed [2,3], SMA pathology                        function neurons muscles SMA pathology remarkably specific. Patients lose spinal motorneurons                       difficult determine. Various tissue requirements SMN
experience muscular dysfunction atrophy. Mild cases result                    function observed different SMA model systems
slowly progressing muscular weakness, severe cases dramat-                      [23–27]. diverse subcellular SMN localization varied
ically perturb proximal neuromuscular function resulting                           cellular requirements SMN function suggest protein
childhood death [4]. effective treatment SMA                          act multiple cellular compartments including 1 40 people population carriers                      neuromuscular junction (NMJ) [28].
SMN loss function disease alleles [5–7].                                              determine unbiased fashion cellular    SMN protein component characterized                           molecular pathways particularly relevant SMA pathology,
Gemin complex, assembles splicing machinery eukary-                          researchers turned recently genetic approaches otes [8–10]. SMN associates b-actin mRNA                             vertebrates invertebrates. identification SMN loss anterograde transport neuronal processes suggesting role                     function modifier genes reveal important biochemical
SMN mRNA transport, sub-cellular localization local                         pathways SMA pathology. Studies patients translation [11–15]. addition, SMN post-synaptic                       identified genes act modifiers SMA: SMN2 densities discs muscles RNA processing                      Plastin 3 (PLS3).


        PLoS Genetics | www.plosgenetics.org                                      1                          October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                      Invertebrate Modifiers SMN



  Author Summary                                                            conservation species, genes act SMN loss function
                                                                            modifiers invertebrates important SMA pathology
  Spinal Muscular Atrophy (SMA) common, untreatable,                   humans (e.g. PLS3) [37].
  fatal neuromuscular disease predominately                          recent study, seven P-element transposon insertion
  caused reduced Survival Motor Neuron (SMN) protein                     lines identified Drosophila modified SMN loss function
  function.  use invertebrate models identify                defects, role TGF-beta pathway SMN loss   validate conserved genes play critical role SMN                 function pathology delineated [26].  remains unclear
  loss function neuromuscular defects. Decreased SMN                     P-element lines Drosophila gene near transposon
  function causes growth defects nematode Caenor-                    insertion site responsible modulating SMN phenotypic defects.
  habditis elegans fruit fly Drosophila melanoga-                Drosophila P-element lines carried inducible GAL4-UAS   ster behavioral synaptic connectivity defects
                                                                            drive expression antisense RNAi expression   neurons muscles, respectively.   genetic modifier SMA patients, plastin, affects              neighboring genes depending transposon insertion site. Addi-
  SMN function invertebrate models. undertook                   tionally, insertion P-element itself perturb gene function.
  genome-wide RNAi screen identify genes                         Eliminating ambiguity regarding modifier gene identity   perturbation alters growth defects C. elegans lacking              increase utility Drosophila study.
  SMN. genes validated neuromuscular assays                      explore genetic circuitry affecting SMN activity C.
  nematode fly models SMA. Additionally,                       elegans, Cesmn-1(lf) growth defect phenotype used   used C. elegans model test SMN modifier genes                      metric rapid large-scale genetic screen. Growth   previously identified Drosophila SMA model.                        affected variety changes, body length longevity.
  Combined, cross-species approaches identified                       Subsequently, modifier genes tested using C. elegans
  genes important species                     behavioral assay, pharyngeal pumping, likely   SMN function decreased. Related mammalian proteins                     pertinent SMN loss function neuromuscular defects.   pathways act (including endocytosis                 addition, identify conserved invertebrate SMN modifier genes,
  RNA transport/translational control) likely impor-                utilized previously described Drosophila assays assess genetic
  tant players SMA.                                                      interaction DmSmn Drosophila orthologs C. elegans modifier
                                                                            genes. study Chang workers, DmSmn lethal
   genes encode human SMN protein: SMN1 SMN2.                       phenotype correlated NMJ defects virtually DmSmn SMN1 gene encodes length SMN protein                modifier genes, suggesting lethality neuromuscular
SMN2 gene encodes different transcripts; 10  SMN2                    bouton number effective measures genetic interaction transcripts encode length SMN protein identical               Drosophila SMN ortholog [26].
SMN1 gene product.  change splice                       define conserved genetic modifiers SMN loss consensus sequence, 90  SMN2 transcripts contain stop                  function using C. elegans Drosophila. PLS3
codon beginning exon 7   encode                   orthologs act SMN modifier genes invertebrate species.
truncated protein (called SMNdeltaEx7 D7SMN) diminished               genome-wide RNAi screen C. elegans identified new SMN
function stability [1,29–31]. Humans various numbers            modifier genes, including ncbp-2 flp-4, modify SMN
SMN2 genes; patients copies SMN2 generally                loss function defects Drosophila. Candidate SMN modifier
later onset severe symptoms patients fewer copies         genes identified previous Drosophila screen tested C.
SMN2. Decreased severity delayed onset usually attributed            elegans yielding cross-species modifier genes. Examination increased length SMN levels SMN2 vivo [17,32–36].           literature genes suggested specific cellular pathways
   PLS3 modulate severity SMA. families,              critical genetic modifiers SMN function: endocytosis
daughters lack SMN1 express PLS3 remarkably               RNA processing. pathways pertinent unaffected [37]. PLS3 encodes conserved calcium-binding, actin-           SMN loss function defects patients SMA.
bundling/stabilizing protein broadly expressed various
tissues including blood, muscles neurons [38–40]. Loss           Results
yeast PLS3 ortholog, Sac6p, results defective endocytosis [41,42].
Altering PLS3 levels modified SMN loss function defects                  previously described Cesmn-1(ok355) deletion allele causes zebrafish motorneurons consistent results human families            complete loss Cesmn-1 function referred PLS3 precipitated SMN neuronal tissues [37].               Cesmn-1(lf) [44]. Cesmn-1(lf) recessive; heterozygous animals  increased PLS3  profilin knockdown) did                 overtly normal. facilitate identification heterozygous versus
decrease defects SMA mouse model remains unclear           homozygous animals, utilized balanced strain hT2(bli- PLS3 modify SMN neuromuscular defects [43].                       4(e937) let-?(q782) qIs48[myo-2p::GFP])/Cesmn-1(lf) (abbreviated +/
   Modifier genes identified patient populations clearly             Cesmn-1(lf) [44,46]. Heterozygous +/Cesmn-1(lf) animals express
pertinent SMA pathology.  studies humans                  pharyngeal GFP, homozygous Cesmn-1(lf) progeny express
limited kindred sizes considerations. SMN                   GFP, progeny homozygous hT2 balancer die GFP-
orthologs C. elegans Drosophila melanogaster,       expressing embryos. efficient identify SMA modifier genes powerful             complete loss SMN function causes lethality, C.
invertebrate models. SMN loss function models               elegans homozygous mutant Cesmn-1(lf) survive defined C. elegans Drosophila [18,25,44,45]. Loss            days partial maternal rescue. suggested
Drosophila Smn (DmSmn) causes larval lethality NMJ defects;             +/Cesmn-1(lf) hermaphrodites load sufficient Cesmn-1 maternal
DmSmn function required neurons muscles flies [26].            protein mRNA oocytes support develop-
Loss C. elegans SMN-1 (Cesmn-1) causes neuromuscular                ment embryogenesis early larval stages [44].
function deficits followed larval lethality [44]. Expression          Accordingly, homozygous Cesmn-1(lf) larvae initially resemble wild
Cesmn-1 neurons dramatically restores neuromuscular function,            type animals. Eventually maternally-loaded Cesmn-1 product lost; expression muscles little effect [44]. Given SMN             Cesmn-1(lf) animals grow slowly +/Cesmn-1(lf) siblings,


      PLoS Genetics | www.plosgenetics.org                              2                       October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                        Invertebrate Modifiers SMN

 shorter, sterile, Cesmn-1(lf) animals die reaching        heterozygous populations (Table 1, Rows 1 & 2). Initially, adulthood (Figure 1A). Combined, defects decrease                   counter-intuitive defects Cesmn-1(lf) animals average size Cesmn-1(lf) population versus control animals;            exacerbated Cesmn-1(RNAi).  scenario,
decreased average population size referred             transcripts somatic tissues germline +/Cesmn-
growth defect. growth defect harnessed automated               1(lf) heterozygous animals targeted  consequently,
assay identify Cesmn-1(lf) modifier genes genome-wide screen.         maternally-loaded Cesmn-1 transcript protein depleted                                                                               homozygous Cesmn-1(lf) progeny, abrogating partially observed
C. elegans growth assay                                                       maternal rescue. ability Cesmn-1(RNAi) exacerbate
   validate growth assay SMN modifier gene                       Cesmn-1(lf) defects suggests effects modifier genes identification, demonstrated RNAi knockdown                  assessed using RNAi feeding.
Cesmn-1 invertebrate ortholog Plastin 3 (PLS3) altered                 Knockdown C. elegans PLS3 ortholog, plst-1, increased Cesmn-1(lf) growth. C. elegans gene plst-1 (PLaSTin (actin bundling       average length +/Cesmn-1(lf) population, did protein) homolog-1) encodes predicted protein similar PLS3.              significantly alter average length Cesmn-1(lf) animals
   knockdown gene function, C. elegans reared bacteria             (Table 1, Rows 1 & 3). Genetic interaction plst-1 producing double stranded RNA corresponding gene                    confirmed using plst-1 (tm4255) mutant allele (Table 2).  strategy known ‘feeding RNAi’ [47]. Feeding RNAi               average length +/Cesmn-1(lf);plst-1(tm4255) adult animals decreases gene transcripts C. elegans tissues                significantly increased relation +/Cesmn-1(lf) animals. knockdown neurons generally effective knockdown               contrast, average length homozygous Cesmn-1(lf);plst- muscles, germline, tissues [48–50].  animals                1(tm4255) altered, recapitulating results plst- reared generations solid media RNAi feeding               1(RNAi). Increased average adult length overall growth
bacteria corresponding Cesmn-1 plst-1, allowing knockdown            metric thzat encompass variety changes; decreased plst-1
maternal zygotic transcripts (Figure 1B). Bacteria containing             function, RNAi mutant allele, increase length, cause RNAi feeding vector used negative control                 sterility, increase longevity +/Cesmn-1(lf) control
 RNAi)).                                                                animals. appears loss Cesmn-1 function suppresses    automated used simultaneously measure                     effects decreased plst-1 function  e. increased length growth determine genotype progeny +/Cesmn-1(lf)                observed Cesmn-1(lf);plst-1(tm4255) homozygous mutant ani-
animals (Figure 1C). COPAS BioSorter (Union Biometrica,                   mals). genetic functional relationship SMN Holliston, MA) measures C. elegans length ‘time flight’,          PLS3 bears examination; plst-1 Cesmn-1 time required animal pass                       opposing effects growth assay Cesmn-1(lf);plst-
fluorescence-detection chamber [51]. Cesmn-1(lf) homozygous                   1(tm4255) animals resemble Cesmn-1(lf) single mutants, Cesmn-1
animals express GFP +/Cesmn-1(lf) heterozygous                   act downstream plst-1 growth assay [52].
animals express GFP longer Cesmn-1 homozygous
animals late larval adult stage. Animals smaller          Growth modifier genes identified C. elegans L2 larval stage excluded analysis avoid                 genome-wide screen
bacterial debris. percentage large adult animals                     identify additional genes modify SMN loss function
determined genotype RNAi treatment.                              defects, large-scale genome-wide screen enhancers    RNAi knockdown Cesmn-1 decreased percentage large                suppressors Cesmn-1(lf) growth defect undertaken. animals Cesmn-1(lf) homozygous +/Cesmn-1(lf)                      growth assay adapted higher-throughput 96  liquid




Figure 1. Survival average length Cesmn-1(lf) animals decreased. Homozygous loss Cesmn-1(lf) results slower growth animals die larval stages. Animals reach adult stage short-lived sterile.  Image age-matched heterozygous
hT2(lethal)[myo-2p::GFP]/Cesmn-1(lf) (+/Cesmn-1(lf), described text) homozygous Cesmn-1(lf) individuals  . Scale bar indicates 150
microns. B) test impact candidate modifier genes growth rates size, C. elegans growth assay established. +/Cesmn-1(lf) animals collected unhatched eggs, reared 5 days/2 generations standard C. elegans plates RNAi bacterial strains, illustrated flow
chart. Bacterial cultures expressed dsRNA corresponding gene RNAi knockdown; bacterial cultures containing vector insert used control ( ). C) Using automated  length fluorescence animals determined [51]; smallest
larvae culture indistinguishable debris excluded analysis illustrated graph. Genotypes discriminated GFP fluorescence length determined ‘time flight’ laser chamber; dot graph represents individual animal. disparate growth/survival rates Cesmn-1(lf) +/Cesmn-1(lf) animals alters percentage ‘large’ animals mixed
stage cultures. illustrated graphically, +/Cesmn-1(lf) Cesmn-1(lf) animals sorted blue red boxes, respectively; animals
designated ‘large’ fall shaded boxes. fraction large animals calculated (# animals shaded box/# animals shaded unshaded box genotype) reported   large standard error mean (S.E.M.); significance determined Mann-Whitney
U tailed test p#0.05. independent cultures 200 animals scored targeted gene.
doi:10.1371/journal.pgen.1001172.g001


       PLoS Genetics | www.plosgenetics.org                               3                        October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                                      Invertebrate Modifiers SMN



 Table 1. Conserved genes modify Cesmn-1(lf) defects                                  animals, growth ratio large small animals determined
 growth assay.                                                                               clone Cesmn-1(lf) +/Cesmn-1(lf) genotypes.                                                                                              RNAi clone growth ratio 2 standard deviations
                                                                                             away mean Cesmn-1(lf) animals 0.7
 Ce gene          Dm gene            Cesmn-1(lf)               +/Cesmn-1(lf)                 standard deviations mean +/Cesmn-1(lf) animals                                                                                              40  independent trials, corresponding gene                                        large ± SEM               large ± SEM                 designated Cesmn-1(lf) modifier (Figure 2B). primary
                           1862                      4661                          high-throughput screen, suppressors  genes
 Cesmn-1          Smn                664*                      3161*                         identified enhancers (Figure 2B). RNAi knockdown                                                                                              genes exacerbated homozygous Cesmn-1(lf) growth defects
 plst-1           Fimbrin            1563                      5563*
                                                                                             did significantly alter growth heterozygous +/Cesmn-
 uso-1            p115               764*                      4461                          1(lf) animals: ncbp-2, T02G5.3, grk-2, flp-4. ncbp-2 encodes  nhr-85           Eip75B             865*                      4461                          C. elegans Cap Binding Protein 20 (CBP20 Cbp20) ortholog
 egl-15           Breathless         965*                      4561                          [54]. T02G5.3 encodes predicted protein unknown function
 atf-6            Atf6               1167*                     4064                          vertebrate orthologs based BLAST analysis. grk-2
                                                                                             encodes G-protein coupled receptor kinases. flp-4
 ape-1            CG18375            1169*                     5062
                                                                                             encodes FMRFamide family neuropeptide protein. low
 kcnl-2           SK                 1261*                     4261
                                                                                             number modifiers identified screen versus previous
 nekl-3           Nek2               1363*                     4362                          Drosophila screen reflect stringent criterion utilized  atn-1            Actinin            2364*                     4361                          inefficiency RNAi feeding neurons.
 cash-1           CG33172            2665                      64611*                           determine decreased adult body length accounts  dlc-1            cut             1568                      6663*
                                                                                             enhanced Cesmn-1(lf) growth defect knockdown ncbp-2,
                                                                                             T02G5.3, grk-2 flp-4, average body length Cesmn-1(lf)
 C. elegans modifier genes listed column 1 orthologous Drosophila                 young animals determined (Text S1 Table S4, panel).
 genes listed column 2. genes significantly altered                     ncbp-2(RNAi) significantly reduced average body length  percentage large Cesmn-1(lf) homozygous animals (column 3) +/Cesmn-
                                                                                             Cesmn-1(lf) animals suggesting enhanced growth defect
 1(lf) heterozygous animals (column 4) presented. Animals reared  generations bacterial RNAi strains targeting C. elegans gene prior            caused ncbp-2(RNAi) attributed Cesmn-1(lf)
 growth analysis described Figure 1. percentage large animals               shorter body size. enhancer genes alter
 determined genotype RNAi knockdown indicated C.                       survival growth adult animals.
 elegans gene reported standard error mean (S.E.M.). Large                   SMA neuromuscular disease   objective  animals include adults, L4 L3 stage larvae. assay does distinguish
 slow growth, changes relative length, altered viability.            identification modifier genes impact SMN neuromuscular
 independent determinations undertaken genotype/RNAi                       function. examined impact Cesmn-1 growth modifier
 culture percentage large animals trial averaged.                     genes Cesmn-1 loss function neuromuscular defects using RNAi
 Significant changes RNAi) RNAi/genotype using                    available, loss function alleles modifier genes.
 tailed Mann-Whitney U test (p,0.05) indicated asterisk. Table
 S1 results genes tested Materials Methods details.
 doi:10.1371/journal.pgen.1001172.t001                                                       RNAi knockdown ncbp-2, grk-2, T02G5.3 modified
                                                                                             Cesmn-1(lf) neuromuscular defects
culture format previously described genome-wide C. elegans                                recent study Sattelle laboratory demonstrated loss
RNAi feeding library used gene knockdown (Figure 2A)                                 Cesmn-1 function causes progressive defects C. elegans
[53]. Progeny +/Cesmn-1(lf) animals reared weeks                             neuromuscular function pharyngeal pumping [44]. C. elegans
 2 generations) RNAi feeding bacterial strains                           feeds bacteria microorganisms using small, discrete
assessment growth using COPAS Biosorter [51]. identify                             subset neurons muscles contained pharynx (Figure 3A)
RNAi clones specifically altered growth Cesmn-1(lf)                              [55]. Pharyngeal cell specification, neuronal development,                                                                                              myoblast fusion completed hours hatching [56,57].                                                                                              pharynx pumps continuously symmetrically 250 beats
 Table 2. C. elegans orthologs PLS3, GRK, FMRFamide
                                                                                             minute wild type animals food present larval
 modify Cesmn-1(lf) growth defects.
                                                                                             pumping interrupted molting standard culture
                                                                                             conditions. confirmed previous report [44] early larval
                                                                                             stages, pumping rates Cesmn-1(lf) animals indistinguish-
 Ce genotype           Ce gene          Cesmn-1(lf)             +/Cesmn-1(lf))
                                                                                             able control animals, later larval stages Cesmn-1(lf)
                       RNAi target        large ± SEM             large ± SEM                pumping rates drop (Figure 3B).Cesmn-1(lf) animals progressive
                                   2762                    4462                         defects pharyngeal pumping, occur earlier reported
                                                                                             locomotion defects. day 2, 62  Cesmn-1(lf) animals moving
 plst-1(tm4255)                    3965                    6762*
                                                                                             spontaneously, pumping rates dropped dramatically
 grk-2(rt97)                       1061*                   4161                         (Figure 3B). Restoration Cesmn-1 function neurons  flp-4(yn35)                       2062                    5162                         completely restores pumping rates suggesting Cesmn-1                                                                                              required neurons behavior [44].
 growth defects +/Cesmn-1(lf) Cesmn-1(lf) animals examined  presence grk-2(rt97), flp-4(yn35) plst-1(tm4255) loss function alleles;          efficacy RNAi feeding neuromuscular assay
 alleles modifer gene listed column 1. percentage large               assessed Cesmn-1 plst-1 using Cesmn-1(lf) +/Cesmn-
 animals determined Cesmn-1(lf) homozygous animals (column 3)                     1(lf) animals. Animals allowed hatch RNAi feeding
 +/Cesmn-1(lf) heterozygous animals (column 4). independent                   plates pumping rates determined days.  determinations undertaken genotype. Significance versus control
 genotypes (+/Cesmn-1(lf) Cesmn-1(lf)) determined using Chi-square
                                                                                             plst-1(RNAi) Cesmn-1(RNAi) decreased Cesmn-1(lf) pumping
 analysis (p,0.05 indicated asterisk). S.E.M. reported.                      rates, +/Cesmn-1(lf) pumping rates (Figure 3C).  doi:10.1371/journal.pgen.1001172.t002                                                       addition, plst-1(lf) significantly decreased pumping rates 

          PLoS Genetics | www.plosgenetics.org                                           4                       October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                          Invertebrate Modifiers SMN




Figure 2. Genome-wide RNAi screen Cesmn-1(lf) modifier genes.  identify genes knockdown modifies growth Cesmn-
1(lf) animals, progeny hT2(lethal)[myo-2p::GFP]/Cesmn-1(lf) (+/Cesmn-1(lf), described text) reared 2 generations 96 
liquid culture format bacteria expressing dsRNA corresponding 16,500 C. elegans genes. Modifier genes identified assay tested
subsequently neuromuscular assays C. elegans Drosophila. B) Cesmn-1(lf) +/Cesmn-1(lf) length measured RNAi clone ‘growth’ ratio large:small animals determined genotype. Representative graphs illustrate distribution RNAi clone growth ratios.
Candidate enhancer genes growth ratio 2 standard deviations mean Cesmn-1(lf) (shaded right graph) 0.7 standard deviations mean +/Cesmn-1(lf) (shaded left graph) 96 plate. suppressors identified using
similar criteria. independent determinations clone original screen. Candidate genes retested quadruplicate enhanced growth 40  trials designation growth modifier genes; average growth ratios enhancers C. elegans screen indicated.
doi:10.1371/journal.pgen.1001172.g002

Cesmn-1(lf) animals, validating genetic interaction plst-1            test genetic interaction flp-4 Cesmn-1, Cesmn-1 neuromuscular pharyngeal pumping assay                          identified flp-4 loss function allele, flp-4(yn35), using PCR
(Figure 3D). exacerbation Cesmn-1 loss function defects             based screening techniques [61–65]. flp-4(yn35) deletion plst-1 manipulation consistent results organisms           removes sequences encoding FLP-4 FMRFamide neuropep-
[37]. ability Cesmn-1(RNAi) plst-1(RNAi) alter                   tides likely causes complete loss flp-4 function ([66] C.
pumping homozygous mutant Cesmn-1(lf) animals suggests                 Li, preparation). flp-4(yn35) reduced percentage candidate modifier genes assessed using RNAi knockdown                  Cesmn-1(lf) large animals growth assay, difference neuromuscular assay.                                                   statistical significant different (Table 2). Similar results    modifier genes C. elegans growth screen              obtained using pharyngeal pumping assay. pumping rates
tested function Cesmn-1 neuromuscular modifier genes using          flp-4(lf) animals slightly lower, significantly
pharyngeal pumping assay. Results summarized Figure 4A.                 different control animals. Loss flp-4 function decreased
ncbp-2(RNAi) T02G5.3(RNAi) enhanced suppressed                     pumping rates Cesmn-1(lf) animals independent trials, pharyngeal pumping defects Cesmn-1(lf) animals, respectively; flp-          difference statistically significant (p = 0.236, Figure 4B).
4(RNAi) grk-2(RNAi) significant effect compared                  flp-4 bona fide modifier flp-4(RNAi) act 
controls. suggest ncbp-2 T02G5.3 likely modifiers           target decreasing function 32 C.
Cesmn-1(lf) neuromuscular defects based RNAi results.                       elegans FMRFamide genes [67].

Loss grk-2 enhances Cesmn-1(lf) growth                                  Drosophila orthologs plst-1, ncbp-2 flp-4 modify
neuromuscular defects                                                          SMN neuromuscular defects
   RNAi knockdown C. elegans genes feeding robust                     SMN modifier genes conserved species virtually cell types inefficient result        considerable  candidate genes identified partial loss gene function, especially nervous           C. elegans screen encode conserved proteins clear orthologs
[58,59]. address specificity genetic modifiers,              species: grk-2, flp-4, ncbp-2. determine RNAi results confirmed using mutant alleles                       orthologs modify SMN loss function defects, turned possible; alleles ncbp-2 T02G5.3 available.                    fruit fly Drosophila. Decreased function Drosophila SMN
   grk-2 loss function allele previously described, grk-         ortholog Smn (DmSmn) results growth defects, early pupal
2(rt97) [60]. Loss grk-2 significantly enhanced growth defects          arrest, NMJ synaptic defects [26]. utilized pre-existing Cesmn-1(lf) animals (Table 2). Additionally, pumping rates           Drosophila loss function alleles previously described Drosophila
grk-2(lf) animals derived hT2 parents significantly              assays assess genetic interaction DmSmn Drosophila
lower control animals, average pumping rates             orthologs C. elegans modifier genes [18,25,26]. Cesmn-1(lf) grk-2(lf) double mutant animals significantly                  determined Fimbrin (Fim), Drosophila ortholog lower pumping rates single mutant (Figure 4B).              PLS3, modifies DmSmn loss function defects growth suggests grk-2 loss enhances Cesmn-1(lf) growth             NMJ assays. shown RNAi knockdown DmSmn
pharyngeal pumping defects. grk-2 gain function allele             (DmSmn RNAi) results 44  lethality early pupal stages available transgenes unstable +/Cesmn-1(lf) animals                 56  lethality late pupal stages [26]. Loss Fim does (unpublished results [44]).                                                cause larval pupal lethality (data shown). Fim loss 

       PLoS Genetics | www.plosgenetics.org                                5                        October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                        Invertebrate Modifiers SMN




Figure 3. Loss C. elegans PLS3 ortholog enhances pharyngeal pumping defects Cesmn-1(lf) animals. feeding C.
elegans pharynx contracts 200 times minute capture grind bacteria.  Pharyngeal pumping rates determined videotaping feeding counting contractions movement grinder (indicated arrow) slower playback speeds; scale bar indicates 40
microns. B) progeny hT2(lethal)[myo-2p::GFP]/Cesmn-1(lf) (+/Cesmn-1(lf)) animals allowed hatch bacterial strains standard C.
elegans plates. Pumping rates +/Cesmn-1(lf) heterozygous Cesmn-1(lf) homozygous animals determined different days (day 1–4) control  vector’ bacterial strain. Decreased locomotion (sinusoidal movement) scored uncoordinated (Unc). day 1, pumping
rates locomotion Cesmn-1(lf) animals identical +/Cesmn-1(lf) wild type animals. day 2, average pumping rates dropped
dramatically  previously reported [44]) roughly 20  animals uncoordinated (column right). day 3 4, pumping rates locomotion majority surviving animals defective. Expressing Cesmn-1 neurons sufficient restore pumping rates near normal
levels [44]. behavior Cesmn-1(lf) animals initially normal maternal loading Cesmn-1 gene products, maternal contribution depleted, loss Cesmn-1 causes progressive defects neuromuscular function. C) Pumping rates +/Cesmn-1(lf) Cesmn-1(lf) animals determined 3 days post-hatching bacterial feeding strains expressing dsRNA corresponding Cesmn-1 plst-1 genes;  vector’
bacterial cultures used control ( ). plst-1(RNAi) Cesmn-1(RNAi) significantly descreased Cesmn-1(lf) pumping rates, +/Cesmn-
1(lf) pharyngeal pumps. D) Decreasing plst-1 function effect pumping rates heterozygous +/Cesmn-1(lf) animals, pumping rates significantly decreased Cesmn-1(lf); plst-1(tm4255) double mutant animals. 20 animals scored genotype 2
independent trials. Pumping rates reported average animals trials. known impact chromosomal pairing histone methylation gene expression [96], animals tested progeny animals carrying hT2 balancer chromosome prevents recombination. S.E.M. reported. Significance p#0.05 indicated asterisk determined using unpaired 
sample t-test Mann-Whitney U tailed test according sample-specific parameters [100].
doi:10.1371/journal.pgen.1001172.g003


function alleles crossed DmSmn(RNAi) background                 decreased suggesting loss Fim function exacerbated DmSmn accelerated death compared DmSmn(RNAi) control                    loss function defects, consistent studies vertebrate
animals (Figure 5A).                                                          models SMA [37]. results suggest PLS3 cross-
   Drosophila, loss SMN function results dose-dependant            species modifier SMN function.
decrease process arborization NMJ diminished numbers                Drosophila orthologs candidate SMN modifier genes synaptic specializations, termed synaptic boutons [26]. Boutons        C. elegans examined. Cbp20 Fmrf selected visualized coincident pre-synaptic synaptotagmin post-                 Drosophila orthologs ncbp-2 flp-4, respectively, based synaptic Discs large protein immunoreactivity. number                  similarity Drosophila loss function alleles obtained.
synaptic boutons Drosophila neurons muscles                  32 genes C. elegans encoding 32 FMRFamide-related
provides simple readily quantifiable assessment phenotypic           neuropeptides, contrast, FMRFamide genes exist severity. determined Drosophila PLS3 ortholog Fim             Drosophila. redundancy FMRFamide gene modify NMJ defects DmSmn. RNAi knockdown                       function Drosophila [68,69,70]).
DmSmn using ubiquitous tubulin promoter (TubGAL4;SmnR-                       Heterozygous loss DmSmn function +/Smn73Ao NAi) modestly decreased synaptic innervation Drosophila larvae             +/Smnf01109 animals significant effect bouton number
(reported bouton numbers muscle area, Figure 5B). Loss              expected, Smn73Ao/Smnf01109 animals dramatically
Drosophila Fim function Fimd02114 animals modestly decreased          decreased bouton numbers (Figure 6). Loss copy bouton density. effects Fimd02114 DmSmn                  Cbc20 Fmrf modestly decreased synaptic bouton number
knockdown synergistic; bouton numbers significantly                 compared control animals.  simultaneous loss 

       PLoS Genetics | www.plosgenetics.org                               6                        October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                         Invertebrate Modifiers SMN




Figure 4. C. elegans RNAi screen identifies conserved SMN modifier genes.  genes identified modifiers Cesmn-1(lf) growth
defects C. elegans RNAi screen: ncbp-2, T02G5.3, grk-2 flp-4. pharyngeal pumping rates homozygous mutant Cesmn-1(lf) heterozygous control +/Cesmn-1(lf) animals determined day 3 described Figure 3. B) C. elegans candidate modifier genes, flp-4 grk-2, loss function alleles available. grk-2(rt97) significantly decreased pumping rates Cesmn-1(lf) animals, flp-4(yn35)
lowered Cesmn-1(lf) pumping rates, did reach statistical significance (p = 0.012 p = 0.236 tailed Mann-Whitney U test, respectively).
Pumping rates determined day 3 post-hatching; 25 animals scored genotype 3 independent trials. Pumping
rates reported average animals trials. Significance versus Cesmn-1(lf) indicated asterisk. control genetic
background, animals tested progeny animals carrying balancer chromosome hT2[myo-2p::GFP]; control animals hT2/Cesmn-1(lf)
siblings.
doi:10.1371/journal.pgen.1001172.g004


copy DmSmn copy modifier gene resulted                 significantly alter percentage large heterozygous +/Cesmn- synaptic bouton loss (Figure 6). genetic interaction            1(lf) animals. Knockdown C. elegans ortholog atn-1 significantly
trans-heterozygous animals consistent strong genetic                 suppressed growth defects Cesmn-1(lf) animals altering
interaction Smn modifier genes.                    percentage large +/Cesmn-1(lf) siblings. Finally, C. elegans
unable obtain classical alleles grk-2 Drosophila ortholog.        orthologs Drosophila genes identified, genetic
conclude Cbp20 FMRFamide conserved invertebrate                   interaction Cesmn-1 resembled interaction plst-1 enhancers Smn loss function defects genetic                Cesmn-1: cash-1 dlc-1. RNAi knockdown genes
interaction conserved species.                                       increased percentage large animals +/Cesmn-1(lf)
                                                                               population altering Cesmn-1(lf) population. Growth
Testing Drosophila modifier genes C. elegans assays                         assay results genes Table 1 (Rows 4
   previous Drosophila screen identified seven P-element              13), results orthologs tested Table S1,
insertion lines altered Drosophila SMN (DmSmn) loss function           discussion modifier gene function presented Text S2.
defects [26]. Cross-species validation genes help             bona fide cross-species modifier genes, impact modifier
elucidate conserved pathways critical SMN loss                  genes SMN loss function defects conserved function pathology.  genes flanked P-element               species  e. enhancer genes enhance species).                                                                                cross-species genes, impact modifier gene loss DmSmn
insertion site modifier lines precise DmSmn
                                                                               Cesmn-1 loss function defects conserved expected.
modifier gene unambiguously identified.  40
                                                                               Specifically, enhancement Cesmn-1(lf) defects RNAi
candidate modifier genes reported [26]. identified                                                                                knockdown nhr-85, egl-15, kcnl-2 consistent likely C. elegans orthologs 32 40 genes using reciprocal
                                                                               effects corresponding Drosophila modifier genes DmSmn
BLAST similarity searching (Table S1). ability genes                                                                                [26]; corresponding Drosophila insertion lines (d09801, f02864,
modify Cesmn-1(lf) growth defects assessed feeding Cesmn-1(lf)
                                                                               d03336) enhanced DmSmn defects transposon +/Cesmn-1(lf) animals bacteria expressing corresponding
                                                                               insertion lines predicted decrease function. dsRNA; RNAi feeding clones constructed B0432.13, dhs-22
                                                                               results Drosophila orthologs C. elegans uso-1 nekl-3 ugt-49 [53]. genes crossed species modified Cesmn-
                                                                               consistent species. exacerbation Cesmn-1(lf)
1(lf) defects C. elegans assays.                                growth defects observed uso-1(RNAi) nekl-3(RNAi) knock-
                                                                               consistent suppression DmSmn defects
Orthologs Drosophila genes modified Cesmn-1(lf)                         observed expression cognate Drosophila genes.
growth defects                                                                 good concordance effect actinin
   Knockdown seven C. elegans genes (uso-1, nhr-85, egl-15, atf-6,          orthologs invertebrate species. d00712 Drosophila
ape-1, kcnl-2 nekl-3) orthologous DmSmn modifier genes                  insertion line likely drives expression Drosophila gene
specifically enhanced Cesmn-1(lf) growth defects, did                  Actinin (Actn) enhances DmSmn defects [26,71,72], 

       PLoS Genetics | www.plosgenetics.org                                7                       October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                         Invertebrate Modifiers SMN




Figure 5. Loss PLS3 orthologs enhances SMN loss function defects invertebrates. Previous studies vertebrates suggested PLS3 orthologs C. elegans Drosophila modify SMN loss function defects [37].  genetic interaction Drosophila PLS3 ortholog (Fimbrin Fim) DmSmn using previously described DmSmn RNAi knockdown lines [26] Fim loss function
alleles. Percentage early late larval lethality reported. Ubiquitous RNAi knockdown DmSmn using tubulinGAL4 (TubGAL4) driver results pupal death; modifier genes alter percentage animals die early versus late pupal stages (day 7 versus day 9 [26]). Loss Fim function
significantly increased percentage animals died early pupae (p#0.05 Chi-square analysis); Fim enhancer DmSmn loss function growth/survival defects. 100 animals genotype scored replicates lethality assay. significant variation observed control experimental crosses independent trial. B) Drosophila d02114 allele likely eliminates Fim function homozygous animals modestly perturbs NMJ morphology larval muscle 4. Fimd02114 enhances DmSmn loss function NMJ defects
consistent studies vertebrates [37]. strains carry ubiquitous TubGAL4 driver. Significance p#0.05 versus single mutant strains determined ANOVA indicated asterisk; S.E.M. shown. representative images, red corresponds anti-Discs Large (DLG), green anti-synaptotagmin blue DAPI; scale bar indicates 15 microns.
doi:10.1371/journal.pgen.1001172.g005

suppression Cesmn-1(lf) growth defects RNAi knockdown                 pharyngeal pumping assay. RNAi knockdown daf-4
C. elegans atn-1 observed                                             enhanced Cesmn-1(lf) pharyngeal pumping defects, knock-
   genes, unclear results Drosophila orthologs       kncl-2 nhr-25 suppressed Cesmn-1(lf) pumping defects concordant species: atf-6, ape-1, dlc-1 cash-1. atf-        (Table 3, rows 3 5).
6 ape-1, corresponding Drosophila transposons (d05057                daf-4 encodes C. elegans TGF-beta receptor subunits
d05779) inserted 1st intron                     orthologous Drosophila Wit (Witless). C. elegans, daf-4 transcripts predicted orthologous Drosophila genes; accord-            TGF-beta/Dpp pathway function required cell specification
ingly, transposons perturb gene function drive                numerous stages transit stress-resistant, expression predicted 2nd shorter transcript.               long-lived dauer stage [73]. RNAi knockdown daf-4 exacerbated
genes complex genetic interactions Cesmn-1  e. dlc-1           Cesmn-1(lf) pumping defects, consistent effect TGF-beta
cash-1), function Drosophila orthologs ctp CKA likely           pathway manipulation Drosophila [26].
decreased Drosophila insertion lines f02345 f04448,                 RNAi knockdown C. elegans genes diminished Cesmn-1(lf)
suppressed enhanced DmSmn defects, respectively [26].                      pumping defects: kcnl-2 nhr-25. kcnl-2 encodes likely C. elegans
Overall, genes modified DmSmn growth defects                   SK channel subunit nhr-25 C. elegans proteins clearly concordant C. elegans growth data, suggesting             similar Drosophila Usp (Ultraspiracle). clear ortholog conserved roles SMN loss function modifiers.                             Usp C. elegans genome. corresponding
                                                                               Drosophila d00712 transposon insertion line likely drives 
Orthologs Drosophila genes modified Cesmn-1(lf)                       expression Usp resulting enhancement DmSmn defects [26].
neuromuscular defects                                                          consistent C. elegans results. contrast, impact   C. elegans orthologs DmSmn modifier genes identified               SK/kcnl-2 loss growth versus pumping assays discordant. previous Drosophila screen [26] rescreened using                 d03336 transposon insertion located SK gene, likely


       PLoS Genetics | www.plosgenetics.org                                8                       October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                    Invertebrate Modifiers SMN




Figure 6. Loss Drosophila Cbp20 FMRF enhances DmSmn loss function neuromuscular defects. C. elegans modifier
genes, loss function alleles available orthologous Drosophila genes: Cbp20 FMRF [68–70]. Loss Drosophila gene enhanced NMJ defects DmSmn animals. number synaptic boutons A2 segment muscles 6 7 counted instar larvae
(visualized using Discs large synaptotagmin immunoreactivity, shown red green, respectively). Homozygous loss DmSmn DmSmnf1109/DmSmn73Ao animals dramatically decreases bouton number loss copy DmSmn, Cbp20 FMRF little effect. Loss copy Cbp20 FMRF animals heterozygous DmSmn allele significantly decreased bouton numbers. nonallelic
noncomplementation suggests strong genetic interaction conserved modifier genes DmSmn. Scale bar indicates 10
microns representative images; S.E.M. shown graph; transheterozygous combinations significantly different corresponding
single heterozygous controls p#0.05 ANOVA indicated asterisk.
doi:10.1371/journal.pgen.1001172.g006


perturbs SK function, enhances DmSmn growth Drosophila             subset cross-species modifier genes interact, directly NMJ defects [26]. consistent kcnl-2(RNAi) enhance-            indirectly, previously described neurological neuromuscular
ment C. elegans growth defects described  suppression         disease proteins suggesting common neurodegenerative pathways Cesmn-1(lf) pumping defects observed kcnl-2                  work  e. ATF6 VAPB/ALS8 GPRK2 knockdown reflect differences requirement kcnl-2            SMN1 FMRP) [75–77]. determine specific cellular
function neuromuscular tissue relative inefficiency       mechanisms implicated SMN loss function pathology,
RNAi knockdown neurons.                                                 published literature public databases examined                                                                            physical functional interactions cross-species SMN
Modifier gene interactions implicate specific pathways                     modifier genes, SMN neuromuscular disease genes. protein/
                                                                           genetic interaction map assembled presented Figure 7
critical neurodegenerative disease
                                                                           references. note genes implicated endocytosis    address specificity invertebrate SMN modifier
                                                                           mRNA translational regulation unexpectedly predominate genes, impact RNAi knockdown examined                                                                            interaction map. cellular pathways pertinent unrelated pharyngeal pumping defective strain. Loss egl-30
                                                                           SMN loss function pathology.
(ad805), perturbs Gqa function C. elegans, decreases pharyngeal pumping rates [74]. RNAi knockdown did significantly alter egl-30 pharyngeal pumping rates modifier
                                                                           Discussion
gene (Table S3), suggesting genes likely specific             Enormous effort decades resulted modifiers SMN loss function defects.                                 successful identification numerous neurodegenerative disease
   Combined results described define conserved             genes proteins encode.  cases genes modify invertebrate SMN ortholog function           remains considerable controversy perturbation assay C. elegans Drosophila (summarized Table 4).       genes results neurodegeneration [78–81]. SMN plays 


       PLoS Genetics | www.plosgenetics.org                            9                       October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                                       Invertebrate Modifiers SMN



 Table 3. RNAi knockdown candidate genes alters Cesmn-1(lf) neuromuscular defects pharyngeal pumping assay.


                                                   Cesmn-1(lf)                    +/Cesmn-1(lf)                 Cesmn-1(lf)                  Cesmn-1(lf)

                                                     change vs. control RNAi                                    RNAi)                  candidate(RNAi)
 Ce gene                  Dm gene                                                                               Pumps/min

 Cesmn-1                  Smn                      56619*                         10162                         5369                         2766
 plst-1                   Fim                      86621*                         10661                         5369                         4368
 daf-4                    Wit                      71627*                         9362                          3867                         2666
 kcnl-2                   SK                       147650*                        9061                          4267                         4868
 nhr-25                   Usp                      155645*                        9165                          4868                         67611

 C. elegans orthologs DmSmn modifier genes RNAi knockdown altered Cesmn-1(lf) pharyngeal pumping defects listed column 1 column 2,
 respectively. percent ( ) change pumping rates vector RNAi versus candidate gene RNAi determined independently separate experiments
 reported S.E.M. Cesmn-1(lf) homozygous mutant +/Cesmn-1(lf) heterozygous control animals (columns 3 4). pumping rates  genotype/treatment varied day day  food thickness, ),   change versus vector RNAi controls reported used determine significance.
 overall pharyngeal pumping rates columns 5 6 calculated pooling Cesmn-1(lf) animals reared RNAi bacteria indicated (n.40 animals).
 Animals allowed hatch bacterial cultures carrying RNAi vector   RNAi constructs targeting C. elegans genes; pumping rates determined
 3 days early adult late L4 larval stage illustrated Figure 2. Significance (indicated asterisk) determined sample t-test/Mann-
 Whitney U test according sample-specific parameters (p#0.05). additional genes modified growth CG33172/cash-1 CG18375/ape-1 (Table S2), reached
 significance pair-wise comparisons controls.  knockdown enhanced Cesmn-1(lf) pumping defects trials suppressed trials
 resulting significant change overall pumping rates. Table S2 results genes tested Materials Methods details.
 doi:10.1371/journal.pgen.1001172.t003


described ubiquitous role Gemin complex snRNP                            suggested invertebrate modifier screens assembly [8–10], SMA specifically affects neuromuscular                             identified conserved human disease-related genes func-
function, motorneuron survival, leads muscle atrophy.                            tional pathways [83–88].
Given neuromuscular specificity, likely loss                         far, published human SMA modifier
SMN function impacts cellular pathways outside Gemin                             genes: Plastin 3 (PLS3) SMN2. role SMN2 clear complex. addition, given complexity cellular signaling                        provides modicum functional SMN protein.  pathways, genetic pathways directly involved SMN                        role PLS3 SMA controversial unclear PLS3
activity impact SMN loss function pathology. identify                         levels modulate severity SMA patients [37,43]. SMN modifier pathways, used genetic approach.                                 invertebrate PLS3 orthologs act modifiers C. elegans Unbiased genetic screens powerful tools utilize                             Drosophila models. cross-species interaction PLS3 SMN
functional criteria identification genes critical cellular               increases confidence invertebrate models suggests
function. case SMN loss function, genetic screens                      plastin-associated pathways important SMN function
reveal conserved genes pathways important                              fundamental level multiple contexts.
neuromuscular dysfunction pathology independent initial                             bioinformatic analysis presented Figure 7, assumptions roles SMN neurons muscles.                          independently identified cellular pathways connect multiple
identification hitherto unsuspected molecular pathways                          modifier genes SMN: endocytosis RNA processing/
modulate SMN neuropathology, directly indirectly, expected                        translational control pathways. Regarding  note widen range targets SMA therapy development.                              yeast ortholog PLS3, Sac6p, key player endocytosis
   Conserved genes modify SMN loss function defects                          Sac6p levels critical expanded polyglutamine
disparate species likely represent pathways important                      neurodegenerative disease proteins expressed SMN loss function defects pathology. C. elegans Drosophila                    [42,89–91]. suggest 1) cellular mechanisms models used identify SMN loss function                             particular importance SMA pathology 2) modifier genes ‘cross species’. difficult estimate                    unexpected intimate connections exist modifiers SMN loss function missed                               pathways. pair recently published studies genome-wide C. elegans RNAi screen. ‘Growth’ encompasses                              microRNA regulatory RISC complex endocytosis physically
variety factors; slow progression larvae stages,                         functionally coupled non-neuronal cells [92,93]. Interestingly,
reduced growth adult stage, longevity, body size, different                      RISC complex contains Gemin complex proteins; culture format (liquid versus plates), combination                        function Gemin RISC complexes related, directly
Additionally, identification genetic modifiers null allele                 indirectly [20]. speculate normal animals, physically challenging compared identification genetic                            coupling seemingly disparate pathways endocytosis local
modifiers partial loss function alleles [82]. genetic screen                  translational regulation help coordinate synaptic activity identify modifier genes pertinent pathway                              receptor signaling protein translation synaptic
important players missed (e.g. miRNAs). Despite                       development neuron maintenance [94]. Defects endocytosis excellent concordance modifier gene action C. elegans                      suggested previously play pivotal role Drosophila. cases, genes enhanced SMN loss                              neurodegenerative diseases numerous scenarios. diseases,
function defects Drosophila enhanced SMN loss function                       including SMA, perturbation endocytosis result RNA
defects C. elegans vice versa. concordance suggests                    translational control defects, vice versa [92,93]. recent study genetic relationships SMN modifier genes                          demonstrated impaired synaptic vesicle release NMJs severe conserved species. Orthologous genes likely                         SMA mice consistent defects synaptic vesicle endocytosis/
important SMN loss function pathology vertebrate species,                      recycling defects active zone organization [94]. 

          PLoS Genetics | www.plosgenetics.org                                     10                          October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                                  Invertebrate Modifiers SMN



 Table 4. Summary: Invertebrate modifiers SMN loss                                 animals tested progeny hT2(lethal)[myo-
 function.                                                                               2p::GFP] parents. use RNAi sensitive C. elegans mutant
                                                                                         strains avoided behavior normal assays
                                                                                         (Hart, unpublished observations) SMN complex/Sm
                                                                      Change/            proteins implicated miRNA pathways [20,97,98].
 Ce         Dm        Hs                            Change/           Affect             note RNAi knockdown effective. control
 gene       gene      gene                          Affect Ce         Dm                 genetic background effects, animals tested studies  plst-1     Fim       Plastin 3 (PLS3)              RNAi/Cmpx Gr,     Lof/Enh            heterozygous hT2 balancer chromosome progeny                                                     Enh Pump                             hT2 parents unless noted.
                                                                                            plst-1(tm4255) animals obtained Japanese
 daf-4      Wit       TGFb receptor (BMPRII)        RNAi/Enh Pump Lof/Enh
                                                                                         National Bioresource Project backcrossed times
 kcnl-2     SK        SK channel (KCNN3)            RNAi/Enh Gr,      Lof/Enh            study. tm4255 allele 368 base pair deletion
                                                    Sup Pump?
                                                                                         removes calponin-like, actin-binding homology
 nhr-25     Usp       NHR LRH-1 (NR5A2)             RNAi/Sup Pump OE/Enh                 (CH) domains; plst-1(tm4255) likely partial loss function
 uso-1      p115      Vesicle docking (USO1)        RNAi/Enh Gr       OE/Sup             allele. test genetic interaction plst-1 Cesmn-1,  nhr-85     Eip75B    NHR RevErb (NR1D2)            RNAi/Enh Gr       Lof/Enh            backcrossed plst-1(tm4255) allele used create double
 atf-6      Atf6      Atf6 trans. factor (ATF6)     RNAi/Enh Gr       ?/Sup              mutant Cesmn-1(lf). flp-4(yn35) deletion allele isolated
 egl-15     Btl       FGF receptor (FGFR3)          RNAi/Enh Gr       Lof/Enh
                                                                                         PCR-based screening EMS-mutagenized animals. yn35
                                                                                         allele 928 base pair deletion removes exon 3 flp-4 gene
 ape-1      CG18375 p53 inhibition (PPP1R13)        RNAi/Enh Gr       ?/Enh
                                                                                         59 sequences (flanking sequences, ttctgaaaaacttttaataa
 nekl-3     Nek2      NIMA family kinase (NEK7)     RNAi/Enh Gr       OE/Sup             agctcgccgagccgagtctt) [66]. grk-2(rt97) loss function
 atn-1      Actinin   actinin (ACTN)              RNAi/Sup Gr       OE/Enh             allele previously characterized [60].
 cash-1     CG33172 Striatin (STRN)                 RNAi/Cmpx Gr      Lof/Enh               Drosophila stocks maintained standard cornmeal/yeast/
 dlc-1      cut    Dynein light chain (DYNLL2)   RNAi/Cmpx Gr      Lof/Sup            molasses/agar medium 25uC. mutations Smn73Ao                                                                                          Smnf01109 described previously [25]. Cbp20e02787  ncbp-2     CBC20     Cap binding (CBP20)           RNAi/Enh Gr &     Lof/Enh            Piggy-Bac insertion mutation Exelixis collection.                                                     Pump                                 insertion location 59 upstream adjacent start codon  grk-2      Gprk      GRK kinase (ADRBK1)           RNAi/Enh Gr &     n.d.               Cbp20 transcript. FmrfKG1300 Fim alleles loss                                                     Pump                                 function alleles (Flybase). line d03334 unlinked
 flp-4      FMRF      Neuropeptide (NPFF)           RNAi/Enh Gr       Lof/Enh            lethal mutation chromosome. Fimd02114  T02G5.3                                  RNAi/Enh Gr,      n.d.               SmnRNAi; Fimd02114 Tubulin:Gal4 background;                                                     Sup Pump                             Gal4 transgene does alter Smn defects (data shown).
 summary table divided sections corresponding potential
 Cesmn-1(lf) modifier genes originally identified humans, Drosophila, C.           Bioinformatics
 elegans (1 Hs, 40 Dm, 4 Ce, respectively). Species gene names             C. elegans orthologs Drosophila human genes  listed columns. change gene expression             identified BLAST searching NCBI. clear ortholog
 Drosophila GAL4-driven transposon insertion lines C. elegans RNAi
                                                                                         identified reciprocal BLAST analysis, similar
 knockdown listed columns 4 5; effect Drosophila gene function  predicted based solely transposon insertion sites cases. (RNAi: RNAi         C. elegans genes generally tested. plst-1 corresponds exons  knockdown; Lof: loss function; decreased function antisense; OE:             predicted adjacent genes Y104H12BR.1 Y104H12BL.1 based
 expression; ?: unclear; Enh: enhanced SMN loss function defects; Sup:                similarity searching. T02G5.3 corresponds exons T02G5.3,
 suppressed SMN loss function defects, Cmpx: complex genetic interaction;
                                                                                         T02G5.2, T02G5.1 based high-throughput cDNA
 determined, n.d.). Column 4 includes C. elegans assay revealing modifier
 activity (Gr: growth; Pump: pharyngeal pumping.) RNAi knockdown                     sequencing gene prediction programs [99]. New gene
 sufficient modify pumping rates T02G5.3 ncbp-2; mutant alleles            predictions reported Wormbase. assemble  grk-2 exacerbated Cesmn-1(lf) pumping defects. flp-4 loss decreased Cesmn-1(lf)         interaction map Figure 7, literature pertaining modifier
 pumping rates 4 5 trials, did reach significance overall.
                                                                                         gene examined NCBI, AceView, C. elegans yeast line
 Discordance Drosophila C. elegans results indicated ?.
 doi:10.1371/journal.pgen.1001172.t004                                                   databases (Wormbase SGD) identify functional direct
                                                                                         interactions modifier genes neurodegenerative
studies warranted ascertain interdependence endocy-                        disease genes.
tosis translational control pathways explore relevance pathways neurodegenerative disease.                                          Construction RNAi feeding clones B0432.13, dhs-22
                                                                                         ugt-49
Materials Methods                                                                       L4440 vector [47] used clone PCR products
Genetic analysis                                                                         corresponding B0432.13, dhs-22 ugt-49 genes. Plasmids    Cesmn-1(lf) homozygous strains maintained                            transformed bacterial strain HT115(DE3) [47,49]. Primers
infertility; hT2(lethal)[myo-2p::GFP]/Cesmn-1(lf) (hT2[bli-4(e937) let-                  used cloning  B0432.13 forward 59-acaagctctcgacatcgctg-
?(q782)qIs48]  III)) animals fertile maintained using                     39, reverse 59- ttaatcgccgcatcctcttg -39; dhs-22 forward 59-tatgctgtg-
standard techniques [95]. lack homologous pairing                         cagaagcgaag-39, reverse 59-ctgcttgattcctggtgtattc-39; ugt-49 forward
rearranged chromosomes LGI LGIII hT2 animals likely                               59-acgtggatgtagctgaatgg-39, reverse 59- acgtgaagaacagcaacgaac-39.
results increased maternal/zygotic expression Cesmn-1 balanced genes [96]. expected, progeny                        C. elegans growth studies hT2 animals relatively resistant Cesmn-1(RNAi)                                   analysis modifier genes, animals reared compared wild type control strains assays (data                            generations/5 days plates spread bacterial RNAi strains
shown). Consequently, genetic background invariant,                          Ahringer Vidal RNAi libraries [53]. RNAi clones


          PLoS Genetics | www.plosgenetics.org                                      11                       October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                           Invertebrate Modifiers SMN




Figure 7. Interaction map SMN modifier genes.  Numerous published physical functional interactions literature connect invertebrate SMN modifier genes. names vertebrate genes used figure, interactions drawn literature animal species. type interaction represented different colors connecting lines references provided table B. interactions indicated including interactions FGF, TGF-beta neuropeptide signaling pathways endocytosis/cytoskeletal
pathways, dynein interactions APP [101] possible connection VAPB, ALS8 locus, SK channels riluzole [102–106]. interaction analysis exhaustive additional interactions exist. B) type interaction indicated table [107–155]: P
pull  Y yeast 2-hybrid, F functional/genetic, D direct physical interaction. Genes shaded blue cross-species invertebrate modifiers; genes
shaded yellow mammalian genes perturbation cause neurodegeneration; genes outlined grey SMA modifiers drug studies patients. Genes pertinent endocytosis include CIN85, EndoA, Alix, PLS3, CAV1, GPRK, Ataxin2, Profilin, EPS15, Phocein, Dynamin, Striatin;
genes pertinent RNA processing include PABP, CBC20, DcpS, SMN, FMRP. Combined, results published studies support model endocytosis RNA translational control pathways physically functionally coupled [92,93]. normal animals, coupling seemingly disparate pathways help coordinate synaptic activity protein synthesis neuromuscular 
doi:10.1371/journal.pgen.1001172.g007

corresponding modifier genes Table 4 sequenced                    genotype [51]. independent determinations confirm accuracy. hlh-4(RNAi) clone feeding library              undertaken genotype/RNAi culture. Significant changes
incorrect. Cesmn-1(ok355);hlh-4(tm604) double mutant strain               RNAi) calculated RNAi/genotype using
generated. hlh-4(tm604) did affect pharyngeal pumping                   tailed Mann-Whitney U test.
rates Cesmn-(lf) (data shown) hlh-4 excluded analysis. Length GFP fluorescence determined                    C. elegans pharyngeal pumping
using COPAS Biosorter (Union Biometrica, Holliston, MA)                       average pharyngeal pumping rates animals percentage large animals determined                     determined 3 days  25, 25 20uC) post-hatching 

       PLoS Genetics | www.plosgenetics.org                                12                        October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                                              Invertebrate Modifiers SMN

 vector  RNAi)) candidate gene RNAi bacterial                                larvae dissected fixed 5 minutes Bouin’s fixative.
feeding strains. Animals videotaped feeding                                 Stained specimens mounted FluoroGuard Antifade
10 seconds AxioCam ICc1 camera Zeiss Stemi                                    Reagent (Bio-Rad), images obtained Zeiss
SV11 20 666 magnification. Movies slowed                                 LSM510 confocal microscope. Bouton numbers counted
counting pumping rates. Pharyngeal grinder movements                                based Discs large Synaptotagmin staining A2
axis scored pumping event. Average pumping rates (6                              segment muscles 6 7 muscle 4 indicated. standard error mean, S.E.M) genotype/treatment                             ratio muscle area various genotypes normalized calculated independently separate experi-                              wild type. 10–12 animals genotype dissected
ments. percent change pumping rate vector versus                           bouton analysis. ANOVA multiple comparison test
candidate gene RNAi determined trial                                 used statistical analysis.
Cesmn-1(lf) homozygous +/Cesmn-1(lf) heterozygous animals used calculate mean, S.E.M, significance.                                   Supporting Information

C. elegans genome-wide RNAi screen                                                         Table S1 Summary C. elegans growth assays.
   hT2(bli-4(e937) let-?(q782) qIs48[myo-2p::GFP])  III) animals                          doi:10.1371/journal.pgen.1001172.s001 (0.09 MB reared liquid cultures 96 plate format RNAi                           DOC)
feeding strains [53]. independent cultures corre-                             Table S2 Summary C. elegans pharyngeal pumping assays.
sponding C. elegans RNAi feeding clone established.                            doi:10.1371/journal.pgen.1001172.s002 (0.09 MB
Concentrated dsRNA expressing bacteria added cultures                            DOC)
necessary prevent starvation. Cultures maintained 8
days 25uC generate sufficient animals analysis. Length                           Table S3 Invertebrate modifier genes specifically affect Cesmn- fluorescence determined using COPAS BioSorter                                 1(lf) pharyngeal pumping defects.
(Union Biometrica, Holliston, MA). Data exported Excel                               doi:10.1371/journal.pgen.1001172.s003 (0.05 MB
(Microsoft Corp.) analysis. Thirty clones identified                          DOC) modified average length Cesmn-1(lf) animals relative                        Table S4 Body length determinations Cesmn-1(lf) modifier
+/Cesmn-1(lf) siblings trials. genes altered                         genes.
Cesmn-1(lf) size relative +/Cesmn-1(lf) siblings 40                       doi:10.1371/journal.pgen.1001172.s004 (0.05 MB
subsequent trials selected candidate modifier                            DOC)
genes neuromuscular analysis described text.
                                                                                           Text S1 Methods supplementary files.
                                                                                            doi:10.1371/journal.pgen.1001172.s005 (0.02 MB
Drosophila pupal lethality
                                                                                           DOC)
   males virgin females placed fresh food 25uC day 1. Eggs collected 2 days (Set 1),                         Text S2 Supplementary discussion invertebrate modifier parents transferred fresh food. Eggs collected                             genes. 2 days (Set 2), parents discarded. F1 animals                           doi:10.1371/journal.pgen.1001172.s006 (0.33 MB scored 15 days,- 16th day set,                     DOC)
19th day second set, day 1. White pupae scored early stage death black pupae scored late stage                             Acknowledgments
death. Control crosses tubGAL4:FL26B(Smn RNAi) 
crossed wild type strain used control                           grateful advice reagents C. elegans knockout
                                                                                           consortia numerous members C. elegans community including
experimental set. Significance determined Chi-square
                                                                                           Prof. D. B. Sattelle sharing information Cesmn-1(lf) pumping defects
analysis.                                                                                  prior publication. nematode strains used work                                                                                            provided Caenorhabditis Genetics Center.
Drosophila NMJ analysis
  Primary antibodies used following dilutions:                                 Author Contributions
monoclonal anti-DLG (1:500) (Developmental Studies Hybridoma
                                                                                           Conceived designed experiments: MD JNS AW HCC GK JH
Bank), polyclonal anti-Synaptotagmin (1:1000)  gift Hugo
                                                                                           TB MBW JSS CL DVV SAT ACH. Performed experiments: MD JNS
Bellen). FITC- (1:40) Cy5- (1:40) conjugated anti-rabbit                           AW HCC GK JH TB MBW JSS SAT ACH. Analyzed data: MD
anti-mouse secondary antibodies purchased Jackson                                JNS AW HCC GK JH TB MBW JSS DVV SAT ACH. Contributed
Immunoresearch Laboratories. Anti-Disc large used 1:100                                 reagents/materials/analysis tools: CL DVV. Wrote paper: MD JNS
(Hybridoma) anti-HRP used 1:1000 (Cappell). 3rd instar                              AW HCC ACH.

References
  1. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, et al. (1995)                 6. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, et al. (1997)
     Identification characterization spinal muscular atrophy-determining               Identification proximal spinal muscular atrophy carriers patients analysis
     gene. Cell 80: 155–165.                                                                    SMNT SMNC gene copy number. J Hum Genet 60: 1411–1422.
  2. Boda B, Mas C, Giudicelli C, Nepote V, Guimiot F, et al. (2004) Survival motor          7. Ogino S, Leonard DG, Rennert H, Ewens WJ, Wilson RB (2002) Genetic risk
     neuron SMN1 SMN2 gene promoters: identical sequences differential                  assessment carrier testing spinal muscular atrophy. J Med Genet 110:
     expression neurons non-neuronal cells. Eur J Hum Genet 12: 729–737.                 301–307.
  3. Monani UR, McPherson JD, Burghes AH (1999) Promoter analysis                     8. Gubitz AK, Feng W, Dreyfuss G (2004) SMN complex. Exp Cell Res 296:
     human centromeric telomeric survival motor neuron genes (SMNC                      51–56.
     SMNT). Biochim Biophys Acta 1445: 330–336.                                              9. Ohn T, Kedersha N, Hickman T, Tisdale S, Anderson P (2008) functional
  4. Pearn J (1980) Classification spinal muscular atrophies. Lancet 1: 919–922.             RNAi screen links O-GlcNAc modification ribosomal proteins stress
  5. Cusin V, Clermont O, Gerard B, Chantereau D, Elion J (2003) Prevalence                  granule processing body assembly. Nat Cell Biol 10: 1224–1231.
     SMN1 deletion duplication carrier normal populations: implication           10. Hua Y, Zhou J (2004) Survival motor neuron protein facilitates assembly      genetic counselling. J Med Genet 40: e39.                                              stress granules. FEBS Lett 572: 69–74.



       PLoS Genetics | www.plosgenetics.org                                           13                            October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                                               Invertebrate Modifiers SMN


11. Fan L, Simard LR (2002) Survival motor neuron (SMN) protein: role neurite              37. Oprea GE, Krober S, McWhorter ML, Rossoll W, Muller S, et al. (2008)
    outgrowth neuromuscular maturation neuronal differentiation                    Plastin 3 protective modifier autosomal recessive spinal muscular
    development. Hum Mol Genet 11: 1605–1614.                                                     atrophy. Science 320: 524–527.
12. Rossoll W, Jablonka S, Andreassi C, Kroning AK, Karle K, et al. (2003) Smn,               38. Bretscher (1981) Fimbrin cytoskeletal protein crosslinks F-actin     spinal muscular atrophy-determining gene product, modulates axon growth                   vitro. Proc Natl Acad Sci U S 78: 6849–6853.
    localization beta-actin mRNA growth cones motoneurons. J Cell                39. Bretscher  Weber K (1980) Fimbrin, new microfilament-associated protein
    Biol 163: 801–812.                                                                            present microvilli cell surface structures. J Cell Biol 86: 335–340.
13. Francis JW, Sandrock AW, Bhide PG, Vonsattel JP, Brown RH, Jr. (1998)                     40. Glenney JR, Jr., Kaulfus P, Matsudaira P, Weber K (1981) F-actin binding     Heterogeneity subcellular localization electrophoretic mobility                     bundling properties fimbrin, major cytoskeletal protein microvillus core
    survival motor neuron (SMN) protein mammalian neural cells tissues.                    filaments. J Biol Chem 256: 9283–9288.
    Proc Natl Acad Sci U S 95: 6492–6497.                                                   41. Adams AE, Botstein D, Drubin DG (1989) yeast actin-binding protein 14. Giavazzi  Setola V, Simonati  Battaglia G (2006) Neuronal-specific roles               encoded SAC6, gene suppression actin mutation. Science
    survival motor neuron protein: evidence survival motor neuron                        243: 231–233.
    expression patterns developing human central nervous                        42. Kubler E, Riezman H (1993) Actin fimbrin required     J Neuropathol Exp Neurol 65: 267–277.                                                         internalization step endocytosis yeast. EMBO J 12: 2855–2862.
15. Pagliardini S, Giavazzi  Setola V, Lizier C, Di Luca M, et al. (2000)                   43. Bowerman M, Anderson CL, Beauvais  Boyl PP, Witke W, et al. (2009)
    Subcellular localization axonal transport survival motor neuron                    SMN, profilin IIa plastin 3: link deregulation actin
    (SMN) protein developing rat spinal cord. Hum Mol Genet 9: 47–56.                      dynamics SMA pathogenesis. Mol Cell Neurosci 42: 66–74.
16. Gennarelli M, Lucarelli M, Capon F, Pizzuti  Merlini L, et al. (1995) Survival          44. Briese M, Esmaeili B, Fraboulet S, Burt EC, Christodoulou S, et al. (2009)
    motor neuron gene transcript analysis muscles spinal muscular atrophy                 Deletion smn-1, Caenorhabditis elegans ortholog spinal muscular
    patients. Biochem Biophys Res Commun 213: 342–348.                                            atrophy gene, results locomotor dysfunction reduced lifespan. Hum Mol
17. Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford  et al.                           Genet 18: 97–104.
    (1997) survival motor neuron protein spinal muscular atrophy. Hum                  45. Miguel-Aliaga  Culetto E, Walker DS, Baylis HA, Sattelle DB, et al. (1999)
    Mol Genet 6: 1205–1214.                                                                       Caenorhabditis elegans orthologue human gene responsible spinal
18. Rajendra TK, Gonsalvez GB, Walker MP, Shpargel KB, Salz HK, et al. (2007)                     muscular atrophy maternal product critical germline maturation     Drosophila melanogaster model spinal muscular atrophy reveals function             embryonic viability. Hum Mol Genet 8: 2133–2143.
    SMN striated muscle. J Cell Biol 176: 831–841.                                         46. McKim KS, Peters K, Rose (1993) types sites required meiotic
19. Walker MP, Rajendra TK, Saieva L, Fuentes JL, Pellizzoni L, et al. (2008)                 chromosome pairing Caenorhabditis elegans. Genetics 134: 749–768.
    SMN complex localizes sarcomeric disc proteolytic target             47. Timmons L, (1998) Specific interference ingested dsRNA. Nature
    calpain. Hum Mol Genet.                                                                       395: 854.
20. Mourelatos  Dostie J, Paushkin S, Sharma  Charroux B, et al. (2002)                   48. Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J (2001)
    miRNPs: novel class ribonucleoproteins containing numerous microRNAs.                    Effectiveness specific RNA-mediated interference ingested double-
    Genes Dev 16: 720–728.                                                                        stranded RNA Caenorhabditis elegans. Genome Biol 2: RESEARCH0002.
21. Pellizzoni L, Baccon J, Charroux B, Dreyfuss G (2001) survival motor               49. Timmons L, Court DL, (2001) Ingestion bacterially expressed
    neurons (SMN) protein interacts snoRNP proteins fibrillarin                      dsRNAs produce specific potent genetic interference Caenorhabditis
    GAR1. Curr Biol 11: 1079–1088.                                                                elegans. Gene 263: 103–112.
22. Whitehead SE, Jones KW, Zhang X, Cheng X, Terns RM, et al. (2002)                         50. Rual JF, Ceron J, Koreth J, Hao T, Nicot  et al. (2004) improving
    Determinants interaction spinal muscular atrophy disease protein                Caenorhabditis elegans phenome mapping ORFeome-based RNAi library.
    SMN dimethylarginine-modified box H/ACA small nucleolar                              Genome Res 14: 2162–2168.
    ribonucleoprotein GAR1. J Biol Chem 277: 48087–48093.                                     51. Pulak R (2006) Techniques analysis, sorting, dispensing C. elegans 23. Cifuentes-Diaz C, Frugier T, Tiziano FD, Lacene E, Roblot N, et al. (2001)                    COPAS flow-sorting  Methods Mol Biol 351: 275–286.
    Deletion murine SMN exon 7 directed skeletal muscle leads severe                 52. Huang LS, Sternberg PW (2006) Genetic dissection developmental
    muscular dystrophy. J Cell Biol 152: 1107–1114.                                               pathways. WormBook. pp 1–19.
24. Shafey D, Cote PD, Kothary R (2005) Hypomorphic Smn knockdown C2C12                       53. Kamath RS, Ahringer J (2003) Genome-wide RNAi screening Caenorhabditis
    myoblasts reveal intrinsic defects myoblast fusion myotube morphology.                 elegans. Methods 30: 313–321.
    Exp Cell Res 311: 49–61.                                                                  54. Lall S, Piano F, Davis (2005) Caenorhabditis elegans decapping proteins:
25. Chan YB, Miguel-Aliaga  Franks C, Thomas N, Trulzsch B, et al. (2003)                       localization functional analysis Dcp1, Dcp2, DcpS     Neuromuscular defects Drosophila survival motor neuron gene mutant.                      embryogenesis. Mol Biol Cell 16: 5880–5890.
    Hum Mol Genet 12: 1367–1376.                                                              55. Avery L (1993) genetics feeding Caenorhabditis elegans. Genetics 133:
26. Chang HC, Dimlich DN, Yokokura T, Mukherjee  Kankel MW, et al. (2008)                       897–917.
    Modeling spinal muscular atrophy Drosophila. PLoS 3: e3209.                        56. Sulston JE, Horvitz HR (1977) Post-embryonic cell lineages nematode,
    doi:10.1371/journal.pone.0003209.                                                             Caenorhabditis elegans. Dev Biol 56: 110–156.
27. McWhorter ML, Monani UR, Burghes AH, Beattie CE (2003) Knockdown                       57. Sulston JE, Schierenberg E, White JG, Thomson JN (1983) embryonic cell
    survival motor neuron (Smn) protein zebrafish causes defects motor                  lineage nematode Caenorhabditis elegans. Dev Biol 100: 64–119.
    axon outgrowth pathfinding. J Cell Biol 162: 919–931.                                 58. Simmer F, Moorman C, van der Linden  Kuijk E, van den Berghe PV,
28. Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, et al. (2008)                       et al. (2003) Genome-wide RNAi C. elegans using hypersensitive rrf-3
    Reduced SMN protein impairs maturation neuromuscular junctions                      strain reveals novel gene functions. PLoS Biol 1: e12. doi:10.1371/journal.-
    mouse models spinal muscular atrophy. Hum Mol Genet 17: 2552–2569.                         pbio.0000012.
29. Lorson CL, Androphy EJ (2000) exonic enhancer required inclusion                59. Kennedy S, Wang D, Ruvkun G (2004) conserved siRNA-degrading RNase
    essential exon SMA-determining gene SMN. Hum Mol Genet 9:                        negatively regulates RNA interference C. elegans. Nature 427: 645–649.
    259–265.                                                                                  60. Fukuto HS, Ferkey DM, Apicella AJ, Lans H, Sharmeen T, et al. (2004) G
30. Monani UR, Coovert DD, Burghes AH (2000) Animal models spinal                              protein-coupled receptor kinase function essential chemosensation C.
    muscular atrophy. Hum Mol Genet 9: 2451–2457.                                                 elegans. Neuron 42: 581–593.
31. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, et al. (1999)                  61. Barrett PL, Fleming JT, Gobel V (2004) Targeted gene alteration     single nucleotide difference alters splicing patterns distinguishes SMA              Caenorhabditis elegans gene conversion. Nat Genet 36: 1231–1237.
    gene SMN1 copy gene SMN2. Hum Mol Genet 8: 1177–1183.                            62. Gengyo-Ando K, Mitani S (2000) Characterization mutations induced 32. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, et al. (1997) Correlation               ethyl methanesulfonate, UV, trimethylpsoralen nematode
    severity SMN protein level spinal muscular atrophy. Nat Genet                  Caenorhabditis elegans. Biochem Biophys Res Commun 269: 64–69.
    16: 265–269.                                                                              63. Gilchrist EJ, O’Neil NJ, Rose  Zetka MC, Haughn GW (2006) TILLING
33. Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B (2002)                                effective reverse genetics technique Caenorhabditis elegans. BMC
    Quantitative analyses SMN1 SMN2 based real-time lightCycler                         Genomics 7: 262.
    PCR: fast highly reliable carrier testing prediction severity spinal        64. Jansen G, Hazendonk E, Thijssen KL, Plasterk RH (1997) Reverse genetics     muscular atrophy. J Hum Genet 70: 358–368.                                                 chemical mutagenesis Caenorhabditis elegans. Nat Genet 17: 119–121.
34. Wirth B, Herz M, Wetter  Moskau S, Hahnen E, et al. (1999) Quantitative                 65. Lesa GM (2006) Isolation Caenorhabditis elegans gene knockouts PCR
    analysis survival motor neuron copies: identification subtle SMN1                       screening chemically mutagenized libraries. Nat Protoc 1: 2231–2240.
    mutations patients spinal muscular atrophy, genotype-phenotype                    66. Liu T, Kim K, Li C, Barr MM (2007) FMRFamide-like neuropeptides     correlation, implications genetic counseling. J Hum Genet 64:                      mechanosensory touch receptor neurons regulate male sexual turning behavior
    1340–1356.                                                                                    Caenorhabditis elegans. J Neurosci 27: 7174–7182.
35. Lefebvre S, Burglen L, Frezal J, Munnich  Melki J (1998) role                67. Li C, Kim K (2008) Neuropeptides. WormBook. pp 1–36.
    SMN gene proximal spinal muscular atrophy. Hum Mol Genet 7:                            68. Mount SM, Salz HK (2000) Pre-messenger RNA processing factors     1531–1536.                                                                                    Drosophila genome. J Cell Biol 150: F37–44.
36. Burghes AH (1997) deletion deletion? converted.                69. Lasko P (2000) Drosophila melanogaster genome: translation factors RNA
    J Hum Genet 61: 9–15.                                                                      binding proteins. J Cell Biol 150: F51–56.



       PLoS Genetics | www.plosgenetics.org                                              14                          October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                                                 Invertebrate Modifiers SMN


 70. Nambu JR, Murphy-Erdosh C, Andrews PC, Feistner GJ, Scheller RH (1988)                    103. Bensimon G, Lacomblez L, Meininger V (1994) controlled trial riluzole      Isolation characterization Drosophila neuropeptide gene. Neuron 1:                    amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330:
     55–61.                                                                                         585–591.
 71. Roulier EM, Fyrberg C, Fyrberg E (1992) Perturbations Drosophila alpha-                104. Couratier P, Sindou P, Esclaire F, Louvel E, Hugon J (1994) Neuroprotective
     actinin cause muscle paralysis, weakness, atrophy confer                        effects riluzole ALS CSF toxicity. Neuroreport 5: 1012–1014.
     obvious nonmuscle phenotypes. J Cell Biol 116: 911–922.                                   105. Haddad H, Cifuentes-Diaz C, Miroglio  Roblot N, Joshi V, et al. (2003)
 72. Fyrberg E, Kelly M, Ball E, Fyrberg C, Reedy MC (1990) Molecular genetics                   Riluzole attenuates spinal muscular atrophy disease progression mouse
     Drosophila alpha-actinin: mutant alleles disrupt disc integrity muscle                   model. Muscle Nerve 28: 432–437.
     insertions. J Cell Biol 110: 1999–2011.                                                   106. Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa  Middleton S, et al.
 73. Inoue T, Thomas JH (2000) Targets TGF-beta signaling Caenorhabditis                      (2004) mutation vesicle-trafficking protein VAPB causes late-onset
     elegans dauer formation. Dev Biol 217: 192–204.                                                spinal muscular atrophy amyotrophic lateral sclerosis. J Hum Genet
 74. Brundage L, Avery L, Katz  Kim UJ, Mendel JE, et al. (1996) Mutations                   75: 822–831.
     C. elegans Gqalpha gene disrupt movement, egg laying, viability. Neuron               107. Shen V, Liu H, Liu SW, Jiao X, Kiledjian M (2008) DcpS scavenger decapping
     16: 999–1009.                                                                                  enzyme modulate pre-mRNA splicing. RNA 14: 1132–1142.
 75. Gkogkas C, Middleton S, Kremer  Wardrope C, Hannah M, et al. (2008)                    108. Singh J, Salcius M, Liu SW, Staker BL, Mishra R, et al. (2008) DcpS      VAPB interacts modulates activity ATF6. Hum Mol Genet 17:                      therapeutic target spinal muscular atrophy. ACS Chem Biol 3: 711–722.
     1517–1526.                                                                                109. Nonis D, Schmidt MH, van Loo S, Eich F, Dikic  et al. (2008) Ataxin-2
 76. Wang H, Wu LJ, Kim SS, Lee FJ, Gong B, et al. (2008) FMRP acts key                        associates endocytosis complex affects EGF receptor trafficking.
     messenger dopamine modulation forebrain. Neuron 59: 634–647.                        Cell Signal 20: 1725–1739.
 77. Piazzon N, Rage F, Schlotter F, Moine H, Branlant C, et al. (2008) vitro           110. Lim J, Hao T, Shaw C, Patel AJ, Szabo G, et al. (2006) protein-protein
     cellulo evidences association survival motor neuron complex              interaction network human inherited ataxias disorders Purkinje cell
     fragile X mental retardation protein. J Biol Chem 283: 5598–5610.                          degeneration. Cell 125: 801–814.
 78. Bauer PO, Nukina N (2009) pathogenic mechanisms polyglutamine                      111. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, et al. (2004) map      diseases current therapeutic strategies. J Neurochem 110: 1737–1765.                       interactome network metazoan C. elegans. Science 303: 540–543.
 79. Crawford  Pardo CA (1996) neurobiology childhood spinal                         112. Jeong H, F, Melia TJ, Jr., Mazzulli JR, Cui L, et al. (2009) Acetylation
     muscular atrophy. Neurobiol Dis 3: 97–110.                                                     targets mutant huntingtin autophagosomes degradation. Cell 137: 60–72.
 80. Goedert M, Spillantini MG (2006) century Alzheimer’s disease. Science                113. Jia K, Hart AC, Levine B (2007) Autophagy genes protect disease
     314: 777–781.                                                                                  caused polyglutamine expansion proteins Caenorhabditis elegans. Autophagy
 81. Lang AE, Lozano (1998) Parkinson’s disease. parts.                             3: 21–25.
     N Engl J Med 339: 1044–1053.                                                              114. Serra HG, Duvick L, Zu T, Carlson K, Stevens S, et al. (2006) RORalpha-
 82. Jorgensen EM, Mango SE (2002) art design genetic screens:                           mediated Purkinje cell development determines disease severity adult SCA1
     Caenorhabditis elegans. Nat Rev Genet 3: 356–369.                                              mice. Cell 127: 697–708.
 83. Dimitriadi M, Hart AC (2010) Neurodegenerative disorders: Insights               115. Petrelli  Gilestro GF, Lanzardo S, Comoglio PM, Migone N, et al. (2002)
     nematode Caenorhabditis elegans. Neurobiol Dis.                                                endophilin-CIN85-Cbl complex mediates ligand-dependent downregula-
 84. Fiuza UM, Arias (2007) Cell molecular biology Notch. J Endocrinol                    tion c-Met. Nature 416: 187–190.
     194: 459–474.                                                                             116. Kaneko T, Maeda  Takefuji M, Aoyama H, Nakayama M, et al. (2005) Rho
 85. Kim SK (2007) Common aging pathways worms, flies, mice humans.                          mediates endocytosis epidermal growth factor receptor phosphor-
     J Exp Biol 210: 1607–1612.                                                                     ylation endophilin A1 Rho-kinase. Genes Cells 10: 973–987.
 86. Leicht DT, Balan V, Kaplun  Singh-Gupta V, Kaplun L, et al. (2007) Raf                  117. Guillaumond F, Dardente H, Giguere V, Cermakian N (2005) Differential
     kinases: function, regulation role human cancer. Biochim Biophys Acta                   control Bmal1 circadian transcription REV-ERB ROR nuclear
     1773: 1196–1212.                                                                               receptors. J Biol Rhythms 20: 391–403.
 87. Schlegel  Stainier DY (2007) Lessons ‘‘lower’’ organisms: worms,              118. Forman BM, Chen J, Blumberg B, Kliewer SA, Henshaw R, et al. (1994)
     flies, zebrafish teach human energy metabolism. PLoS Genet                    Cross-talk ROR alpha 1 Rev-erb family orphan nuclear
     3: e199. doi:10.1371/journal.pgen.0030199.                                                     receptors. Mol Endocrinol 8: 1253–1261.
 88. Silverman GA, Luke CJ, Bhatia SR, Long OS, Vetica AC, et al. (2009)                       119. Freeman JL, Pitcher JA, Li X, Bennett V, Lefkowitz RJ (2000) alpha-Actinin      Modeling molecular cellular aspects human disease using nematode                    potent regulator G protein-coupled receptor kinase activity substrate
     Caenorhabditis elegans. Pediatr Res 65: 10–18.                                                 specificity vitro. FEBS Lett 473: 280–284.
 89. Kaksonen M, Toret CP, Drubin DG (2005) modular design clathrin-                 120. Chatellard-Causse C, Blot B, Cristina N, Torch S, Missotten M, et al. (2002)
     actin-mediated endocytosis machinery. Cell 123: 305–320.                                   Alix (ALG-2-interacting protein X), protein involved apoptosis, binds  90. Ralser M, Nonhoff U, Albrecht M, Lengauer T, Wanker EE, et al. (2005)                          endophilins induces cytoplasmic vacuolization. J Biol Chem 277:
     Ataxin-2 huntingtin interact endophilin complexes function                    29108–29115.
     plastin-associated pathways. Hum Mol Genet 14: 2893–2909.                                 121. Lu L, Zhang Q, Timofeyev V, Zhang  Young JN, et al. (2007) Molecular
 91. Singer-Kruger B, Nemoto Y, Daniell L, Ferro-Novick S, Camilli P (1998)                      coupling Ca2+-activated K+ channel L-type Ca2+ channels alpha-
     Synaptojanin family members implicated endocytic membrane traffic                    actinin2. Circ Res 100: 112–120.
     yeast. J Cell Sci 111 ( Pt 22): 3347–3356.                                                122. Chen B, Borinstein SC, Gillis J, Sykes VW, Bogler O (2000) glioma-
 92. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O (2009) Multivesicular bodies                       associated protein SETA interacts AIP1/Alix ALG-2 modulates
     associate components miRNA effector complexes modulate                             apoptosis astrocytes. J Biol Chem 275: 19275–19281.
     miRNA activity. Nat Cell Biol 11: 1143–1149.                                              123. Schmidt MH, Hoeller D, Yu J, Furnari FB, Cavenee WK, et al. (2004) Alix/
 93. Lee YS, Pressman S, Andress AP, Kim K, White JL, et al. (2009) Silencing                    AIP1 antagonizes epidermal growth factor receptor downregulation      small RNAs linked endosomal trafficking. Nat Cell Biol 11: 1150–1156.                    Cbl-SETA/CIN85 complex. Mol Cell Biol 24: 8981–8993.
 94. Kong L, Wang X, Choe DW, Polley M, Burnett BG, et al. (2009) Impaired                     124. Carman CV, Lisanti MP, Benovic JL (1999) Regulation G protein-coupled
     synaptic vesicle release immaturity neuromuscular junctions spinal                   receptor kinases caveolin. J Biol Chem 274: 8858–8864.
     muscular atrophy mice. J Neurosci 29: 842–851.                                            125. Ralser M, Albrecht M, Nonhoff U, Lengauer T, Lehrach H, et al. (2005)  95. Brenner S (1974) genetics Caenorhabditis elegans. Genetics 77: 71–94.                   integrative approach gain insights cellular function human ataxin-
 96. Bean CJ, Schaner CE, Kelly (2004) Meiotic pairing imprinted X                           2. J Mol Biol 346: 203–214.
     chromatin assembly Caenorhabditis elegans. Nat Genet 36: 100–105.                      126. Lessing D, Bonini NM (2008) Polyglutamine genes interact modulate  97. Bilinski SM, Jaglarz MK, Szymanska B, Etkin LD, Kloc M (2004) Sm proteins,                     severity progression neurodegeneration Drosophila. PLoS Biol 6: e29.
     constituents spliceosome, components nuage mitochon-                     doi:10.1371/journal.pbio.0060029.
     drial cement Xenopus oocytes. Exp Cell Res 299: 171–178.                               127. Ciosk R, DePalma M, Priess JR (2004) ATX-2, C. elegans ortholog ataxin
 98. Dostie J, Mourelatos  Yang M, Sharma  Dreyfuss G (2003) Numerous                           2, functions translational regulation germline. Development 131:
     microRNPs neuronal cells containing novel microRNAs. RNA 9: 180–186.                        4831–4841.
 99. Hillier LW, Reinke V, Green P, Hirst M, Marra MA, et al. (2009) Massively                 128. Satterfield TF, Pallanck LJ (2006) Ataxin-2 Drosophila homolog, ATX2,
     parallel sequencing polyadenylated transcriptome C. elegans. Genome                  physically assemble polyribosomes. Hum Mol Genet 15: 2523–2532.
     Res 19: 657–666.                                                                          129. Nonhoff U, Ralser M, Welzel F, Piccini  Balzereit D, et al. (2007) Ataxin-2
100. Townend J (2002) Practical statistics environmental biological scientists.             interacts DEAD/H-box RNA helicase DDX6 interferes P-
     Chichester, UK: John Wiley Sons                                                        bodies stress granules. Mol Biol Cell 18: 1385–1396.
101. Gunawardena S, Goldstein LS (2001) Disruption axonal transport                     130. Kozlov G, Trempe JF, Khaleghpour K, Kahvejian  Ekiel  et al. (2001)
     neuronal viability amyloid precursor protein mutations Drosophila. Neuron                Structure function C-terminal PABC domain human poly -
     32: 389–401.                                                                                   binding protein. Proc Natl Acad Sci U S 98: 4409–4413.
102. Cao YJ, Dreixler JC, Couey JJ, Houamed KM (2002) Modulation                            131. Ikezu T, Trapp BD, Song KS, Schlegel  Lisanti MP, et al. (1998) Caveolae,
     recombinant native neuronal SK channels neuroprotective drug                        plasma membrane microdomains alpha-secretase-mediated processing      riluzole. Eur J Pharmacol 449: 47–54.                                                          amyloid precursor protein. J Biol Chem 273: 10485–10495.



        PLoS Genetics | www.plosgenetics.org                                              15                           October 2010 | Volume 6 | Issue 10 | e1001172
                                                                                                                                                Invertebrate Modifiers SMN


132. Massenet S, Pellizzoni L, Paushkin S, Mattaj IW, Dreyfuss G (2002) SMN               144. Shao J, Welch WJ, Diprospero NA, Diamond MI (2008) Phosphorylation      complex associated snRNPs cytoplasmic assembly                       profilin ROCK1 regulates polyglutamine aggregation. Mol Cell Biol 28:
     pathway. Mol Cell Biol 22: 6533–6541.                                                         5196–5208.
133. Gareus R, Di Nardo  Rybin V, Witke W (2006) Mouse profilin 2 regulates                 145. Baillat G, Gaillard S, Castets F, Monneron (2002) Interactions phocein
     endocytosis competes SH3 ligand binding dynamin 1. J Biol Chem                    nucleoside-diphosphate kinase, Eps15, Dynamin  J Biol Chem 277:
     281: 2803–2811.                                                                               18961–18966.
134. Schafer DA, Weed SA, Binns D, Karginov AV, Parsons JT, et al. (2002)                     146. Sittler  Walter S, Wedemeyer N, Hasenbank R, Scherzinger E, et al. (1998)
     Dynamin2 cortactin regulate actin assembly filament organization.                     SH3GL3 associates Huntingtin exon 1 protein promotes      Curr Biol 12: 1852–1857.                                                                      formation polygln-containing protein aggregates. Mol Cell 2: 427–436.
135. Witke W, Podtelejnikov AV, Di Nardo  Sutherland JD, Gurniak CB, et al.                 147. Qin ZH, Wang Y, Sapp E, Cuiffo B, Wanker E, et al. (2004) Huntingtin bodies
     (1998) mouse brain profilin profilin II associate regulators             sequester vesicle-associated proteins polyproline-dependent interaction.
     endocytic pathway actin assembly. EMBO J 17: 967–976.                                     J Neurosci 24: 269–281.
136. Al-Ramahi  Perez  Lim J, Zhang M, Sorensen R, et al. (2007) dAtaxin-2               148. Fallon L, Belanger CM, Corera  Kontogiannea M, Regan-Klapisz E, et al.
     mediates expanded Ataxin-1-induced neurodegeneration Drosophila model                    (2006) regulated interaction UIM protein Eps15 implicates parkin                                                                                                    EGF receptor trafficking PI(3)K-Akt signalling. Nat Cell Biol 8: 834–842.
     SCA1. PLoS Genet 3: e234. doi:10.1371/journal.pgen.0030234.
                                                                                              149. Salcini AE, Hilliard MA, Croce  Arbucci S, Luzzi P, et al. (2001) Eps15
137. Ghosh-Roy  Desai BS, Ray K (2005) Dynein light chain 1 regulates
                                                                                                   C. elegans homologue EHS-1 implicated synaptic vesicle recycling. Nat Cell
     dynamin-mediated F-actin assembly sperm individualization                                                                                                    Biol 3: 755–760.
     Drosophila. Mol Biol Cell 16: 3107–3116.
                                                                                              150. Krishnan KS, Rikhy R, Rao S, Shivalkar M, Mosko M, et al. (2001) Nucleoside
138. Navarro-Lerida  Martinez Moreno M, Roncal F, Gavilanes F, Albar JP, et al.                  diphosphate kinase, source GTP, required dynamin-dependent
     (2004) Proteomic identification brain proteins interact dynein light             synaptic vesicle recycling. Neuron 30: 197–210.
     chain LC8. Proteomics 4: 339–346.                                                        151. Sharma  Lambrechts  Hao le T, Le TT, Sewry CA, et al. (2005) role 139. Pan S, Wang R, Zhou X, G, Koomen J, et al. (2006) Involvement                       complexes survival motor neurons (SMN) protein gemins profilin
     conserved adaptor protein Alix actin cytoskeleton assembly. J Biol Chem                    neurite-like cytoplasmic extensions cultured nerve cells. Exp Cell Res 309:
     281: 34640–34650.                                                                             185–197.
140. Gaillard S, Bartoli M, Castets F, Monneron (2001) Striatin, calmodulin-              152. Giesemann T, Rathke-Hartlieb S, Rothkegel M, Bartsch JW, Buchmeier S,
     dependent scaffolding protein, directly binds caveolin-1. FEBS Lett 508: 49–52.               et al. (1999) role polyproline motifs spinal muscular atrophy protein
141. Khandjian EW, Huot  Tremblay S, Davidovic L, Mazroui R, et al. (2004)                      SMN. Profilins bind colocalize smn nuclear gems. J Biol Chem
     Biochemical evidence association fragile X mental retardation protein              274: 3